Novavax's Unattributed VC - IV Round

Novavax raised a round of funding on July 24, 2008.

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle…

Articles about Novavax's Unattributed VC - IV Round: